Treatment of Rocky Mountain Spotted Fever in Children

Spach DH , Liles WC , Campbell GL , Quick RE , Anderson DE , Fritsche TR . Tick-borne diseases in the United States. N Engl J Med 1993; 329: 936-47.

Jantausch JA . Lyme disease, Rocky Mountain spotted-fever, ehrlichiosis: emerging and established challenges for the clinician. Ann Allergy 1994; 73: 4-11.

Dalton MJ , Clarke MJ , Holman RC , Krebs JW , Fishbein DB , Olson JG , National surveillance for Rocky Mountain spotted fever, 1981- 1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52: 405-13.

Saah AJ . Rickettsiosis. In: Mandell GL , Bennett JE , Dolin R , eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, Inc., 1995: 1719-27.

Walker DH . Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 1995; 20: 1111-7.

Abramson JS , Givner LB . Rickettsial diseases. In: Kaplan SL , ed. Current therapy in pediatric infectious disease. 3rd ed. St. Louis: Mosby-Year Book, Inc., 1993: 241-2.

Kirkland KB , Wilkinson WE , Sexton DJ . Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20: 1118-21.

Dumler JS . Laboratory diagnosis of human rickettsial and ehrlichial infections. Clin Microbiol News 1996; 18: 57-61.

Walker DH , Burday MS , Folds JD . Laboratory diagnosis of Rocky Mountain spotted fever. South Med J 1980; 73: 1443-6.

Hechemy KE , Stevens RW , Sasowski S , Michaelson EE , Casper EA , Philip RN . Discrepancies in Weil-Felix and microimmunofluorescence test results for Rocky Mountain spotted fever. J Clin Microbiol 1979; 9: 292-3.

Rieder MJ . Chloramphenicol. In: Koren G , Prober CG , Gold R , eds. Antimicrobial therapy in infants and children. New York: Marcel Dekker, Inc., 1988: 311-38.

Chloramphenicol. In: McEvoy GK , ed. AHFS 96 drug information. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 1996: 213-7.

Nahata MC . Chloramphenicol. In: Evans WE , Schentag JJ , Jusko WJ , eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed. Vancouver, WA: Applied Therapeutics, Inc., 1992: 1-16-1-24.

Glazko AJ , Carnes HE , Karenko A , Wolf LM , Reunter TF . Succinic acid esters of chloramphenicol. In: Welch H , Marti-Ibanez F , eds. Antibiotics annual 1957-1958. New York: Medical Encyclopedia, Inc., 1958: 792-801.

Committee on Infectious Diseases American Academy of Pediatrics. Rocky Mountain spotted fever. 23rd ed. Elk Grove Village, IL: American Academy of Pediatrics, 1994.

Abramson JS , Givner LB . Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age (editorial)? Pediatrics 1990; 86: 123-4.

Stewart D.J. . Prevalence of tetracycline in children's teeth — Study II: a resurvey after five years. BMJ 1973; 3: 320–2.

Grossman E.R. , Walchek A. , Freedman H. , Flanagan C. . Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 1971; 47: 567–70.

Schach von Wittenau M. . Some pharmacokinetic aspects of doxycycline metabolism in man. Chemotherapy 1968; 13(suppl): 41–50.

Forti G. , Benincori C. . Doxycycline and the teeth (letter). Lancet 1969; 1: 782.

Yagupsky P. , Gross E.M. , Alkan M. , Bearman J.E. . Comparison of two dosage schedules of doxycycline in children with rickettsial spotted fever. J Infect Dis 1987; 155: 1215–9.

Beitran R.R. , Herrero Herrero J.I. . Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992; 11: 427–31.

Schaad U.B. , Salam M.A. , Aujard Y. , Dagan R. , Green S.D. , Peltola H. . Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995; 14: 1–9.